Sigríður Harðardóttir is Investment Director at Kvika Private Equity. She has more than 15 years of experience across pharmaceuticals, medical devices, and digital health. Previously, she held global and leadership roles at Novo Nordisk, Embla Medical (Össur), and Sidekick Health, working across commercial, strategy and research & development. Sigríður holds a BSc in Economics from the University of Iceland and a Master’s degree in International Economics and Finance from Brandeis University.